2003 - Establishment;
2004 - Formation of a R&D team, producing the recombinant
antigen of porcine reproductive and respiratory syndrome virus and the PRRSV
ELISA test kit;
2005 - Over 10 kinds of Animal disease ELISA kits successfully
developed for sale;
2006 - Firstly production of nitrofuran ELISA test kit(4 in 1),
entering the field of food safety detection;
2007 - Accredited as ISO9001 certification and Shenzhen High-Tech
Enterprise;
2008 - Starting to map out international markets and forming a long-term
friendly cooperation with the FDA, FAO and others;
2009 - Over 20 veterinary drug residue detection kits have been
created to address the issue of veterinary medication residues in aquaculture,
making them the market leader in their own country.
2010 - Setup of the first colloidal gold production line for the
production of clenbuterol rapid test kit;
2011 - Relocation to National Biological Industrial Park of
Marinellite, and build-up of the first workshop with immunity GMP standard;
2012 - Formation of an immunology R&D center for study of small
molecule antigens and antibodies;
2013 - Awarded as National Hi-Tech Enterprise;
2014 - Medical Device Manufacturing License approved, entering the IVD field and obtaining the silver medal for
innovation achievements;
2015 - High-level talents have started a new chapter after the
organization was awarded the post-doctoral innovation practice base in
Shenzhen. The dry fluorescent immunoassay obtained the first domestic
registration certificate for medical equipment;
2016 - Accredited as 3A enterprise (Highest credit rating) and
innovative SME filing certificate;
2017 - Obtained 3 in vitro diagnostic reagent registration
certificates issued by China FDA;
2018 - Formation of a Dongguan branch, focusing on the R&D of
rapid detection reagents for pesticide residues;
2019 - Together with Guangdong University of Technology, Tsinghua
University and Tsinghua Research Institute (the leading unit), jointly
participating in the Guangdong key project "New Target Mining and
Detection Chip for Foodborne Pathogenic Microorganism Detection";
2020 - Passing the ISO 13485:2016 certification, developing and
industrializing the COVID-19 IgM/IgG antibody rapid test kit, obtaining CE,
Anvisa and other certifications;
2021 - Obtaining registration certificates from European Union,
Thailand and Malaysia for Covid-19 antigen detection kit. Ranking No.1 in
sensitivity among the 122 brands tested by PEI and becoming a best-selling
product in Germany. Rated as a specialized SME in Guangdong Province with the
veterinary drug GMP certificate; It has been be in great demand in many
overseas countries;
2022 - Rated as the national specialized "little giant"
enterprise, and acquired Shenzhen BIOCUP Biotech Co.,Ltd, a well-known enterprise in
the field of allergen detection.